相关实验视频

Updated: Jun 24, 2025

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

基于结构的虚拟选广的化学空间作为药物发现的起点

Jens Carlsson¹, Andreas Luttens²

¹Science for Life Laboratory, Department of Cell and Molecular Biology, Uppsala University, BMC, Box 596, SE-751 24 Uppsala, Sweden.

Current opinion in structural biology

|June 7, 2024

概括

基于结构的虚拟选 (SBVS) 从庞大的化学图书馆中有效地识别出潜在的药物候选者. 这种计算方法加速了对关键治疗点的早期药物发现.

科学领域:

计算化学是一种计算化学.
药物发现药物发现
生物信息学是一种生物信息学.

背景情况:

基于结构的虚拟查 (SBVS) 计算模型分子相互作用以确定潜在的候选药物.
化学数据库的扩展为选数十亿种化合物的治疗点提供了前所未有的机会.

研究的目的:

为探索超大化学空间提供SBVS战略的简要概述.
突出SBVS在早期药物发现中的成功应用,用于诸如G蛋白结合受体和病毒酶等重要标.
讨论SBVS与机器学习的整合以及未来的挑战.

主要方法:

对分子相互作用的计算建模技术的审查.
分析选超大化学库的策略.
探索虚拟查和机器学习之间的协同作用.

主要成果:

SBVS已经在识别治疗相关标的配体方面取得了成功.
有效的策略存在于导航和选大规模的化学图书馆.
机器学习提高了虚拟选的效率和范围.

结论:

SBVS是加速早期药物发现的强大工具.
先进的计算方法和机器学习的整合将推动未来的药物发现管道.
虚拟查在下一代药物开发中发挥着至关重要的作用.

更多相关视频

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source

Published on: May 29, 2021

Workflow and Tools for Crystallographic Fragment Screening at the Helmholtz-Zentrum Berlin

Workflow and Tools for Crystallographic Fragment Screening at the Helmholtz-Zentrum Berlin

Published on: March 3, 2021

相关概念视频

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...